Hyalex Orthopaedics Investors

23 investors on Angel Roster list Hyalex Orthopaedics in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Series A and the largest groups are based in the United States, the United Kingdom and the Netherlands.

Investors are matched on the company name in their portfolio, so companies that share the name Hyalex Orthopaedics can appear together.

Investors listed
23
With verified email
70%
Most common stage
Series A
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 23 Hyalex Orthopaedics investors

The most complete profiles first. Showing 23 of 23.

  • Eric YoungVerified

    Venture Capital, Founder, Investor · United Kingdom

    SeedSeries BSeries AAdvertisingHealth CareE-commerceMessaging

    Portfolio: Node, OncoResponse, Filanet, Hallo and 85 more

    Verified email available

  • Guy RussoVerified

    Venture Capital, Investor · United States

    Series BSeries AAdvertisingHealth CareE-commerceMessaging

    Portfolio: Node, OncoResponse, Hallo, SeeTree and 81 more

    Verified email available

  • Jared NewmanVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BSeries AAdvertisingHealth CareE-commerceMessaging

    Portfolio: Node, OncoResponse, Hallo, SeeTree and 81 more

    Verified email available

  • Joydeep BhattacharyyaVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BSeries AAdvertisingHealth CareE-commerceCybersecurity

    Portfolio: BoostUp.ai, Node, OncoResponse, Hallo and 84 more

    Verified email available

  • Laura ChauVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BSeries AAdvertisingHealth CareE-commerceMessaging

    Portfolio: Node, OncoResponse, Hallo, SeeTree and 81 more

    Verified email available

  • Louis BernemanVerified

    Venture Capital, University Program, Entrepreneurship Program · United States

    Series AHealth CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more

    Verified email available

  • Manny StockmanVerified

    Venture Capital, University Program, Entrepreneurship Program · United States

    Series AHealth CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more

    Verified email available

  • Robert AdelsonVerified

    Venture Capital, University Program, Investor · United States

    Series AHealth CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 65 more

    Verified email available

  • Tim ShannonVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BSeries AAdvertisingHealth CareE-commerceMessaging

    Portfolio: Node, OncoResponse, Hallo, SeeTree and 83 more

    Verified email available

  • Wende HuttonVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BSeries AAdvertisingHealth CareE-commerceMessaging

    Portfolio: OncoResponse, Apieron, Hyalex Orthopaedics, Calibra Medical and 12 more

    Verified email available

  • Anurag AgarwalVerified

    Venture Capital, University Program, Entrepreneurship Program · United States

    Health CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more

    Verified email available

  • Arpesh MehtaVerified

    Corporate Venture Capital · United States

    Health CareWearablesWellnessWomen Founded

    Portfolio: IntegraGen, ChromaDex, EyePromise, Morphotek and 46 more

    Verified email available

  • Greg McParlandVerified

    Corporate Venture Capital · United States

    Health CareWearablesWellnessWomen Founded

    Portfolio: IntegraGen, ChromaDex, EyePromise, Morphotek and 46 more

    Verified email available

  • Hootan RashidifardVerified

    Venture Capital · United States

    AdvertisingHealth CareE-commerceMessaging

    Portfolio: Node, OncoResponse, Hallo, SeeTree and 81 more

    Verified email available

  • Matt CohenVerified

    Venture Capital, University Program · United States

    Health CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more

    Verified email available

  • Marc Singer

    Venture Capital, University Program, Entrepreneurship Program · United States

    Series AHealth CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 69 more

    Contact details available

  • Nandu Anilal

    Venture Capital, Private Equity Firm, Investor · United States

    Series BSeries AAdvertisingHealth CareE-commerceMessaging

    Portfolio: Node, OncoResponse, Hallo, SeeTree and 81 more

    Contact details available

  • Rayfe Gaspar

    Venture Capital, Private Equity Firm, Investor · United States

    Series BSeries AAdvertisingHealth CareE-commerceMessaging

    Portfolio: Node, OncoResponse, Hallo, SeeTree and 81 more

    Contact details available

  • William Harrington

    Venture Capital, University Program, Investor · United States

    Series AHealth CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 71 more

    Contact details available

  • Byron Ling

    Venture Capital · United States

    AdvertisingHealth CareE-commerceMessaging

    Portfolio: Node, OncoResponse, Hallo, SeeTree and 81 more

    Contact details available

  • Kirsten Leute

    Venture Capital, University Program · United States

    Health CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more

    Contact details available

  • Philip Mertens

    Corporate Venture Capital · Netherlands

    Health CareWearablesWellnessWomen Founded

    Portfolio: IntegraGen, ChromaDex, EyePromise, Morphotek and 46 more

    Contact details available

  • Renee RyanVerified

    Venture Capital, Angel/Individual

    MedicalDiverse Founder Investments

    Portfolio: Cardiac Dimensions, Direct Flow Medical, Hyalex Orthopaedics, ReVision Optics and 1 more

    Verified email available

Frequently asked questions

How many Hyalex Orthopaedics investors are on Angel Roster?

Angel Roster lists 23 Hyalex Orthopaedics investors. 16 of them (70%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (20), Private Equity Firms (11) and University Program Investors (8). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Hyalex Orthopaedics investors invest in?

Among those that list a stage, the most common are Series A (14), Series B (9) and Seed (1).

Where are Hyalex Orthopaedics investors based?

Most are based in the United States (20), the United Kingdom (1) and the Netherlands (1).

Which companies have Hyalex Orthopaedics investors backed?

The most-backed portfolio companies among them are Arrakis Therapeutics (18), OncoResponse (11), Mantra Health (11), Glooko (11) and RenoFi (10).

How do I contact Hyalex Orthopaedics investors?

Create a free Angel Roster account to search and filter all 23, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.